Ching-Hon Pui
Genetics · 2002–2015
A researcher in the Science corpus: 22 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Genetics — 63 citations into it
- Public Health, Environmental and Occupational Health — 57 citations into it
- Pharmacology — 6 citations into it
Whom Ching-Hon Pui trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Ching-Hon Pui's perspective
Ordered by how strongly the researchers Ching-Hon Pui trusts endorse each paper. Same corpus, a different order for every researcher.
- Rearrangement of CRLF2 in B-progenitor– and Down syndrome–associated acute lymphoblastic leukemia (Nature Genetics)
- Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia (New England Journal of Medicine)
- Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments (Statistical Applications in Genetics and Molecular Biology)
- BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros (Nature)
- Reverse engineering cellular networks (Nature Protocols)
- The Polycomb Complex PRC2 and its Mark in Life (Nature)
- Densely interconnected transcriptional circuits control cell states in human hematopoiesis (Cell)
- A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study (The Lancet Oncology)
- The genetic basis of early T-cell precursor acute lymphoblastic leukaemia (Nature)
- Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution (Nature)
Their papers
- Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia (2007) — 1,888 citations
- CREBBP mutations in relapsed acute lymphoblastic leukaemia (2011) — 628 citations
- Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. (2002) — 1,143 citations
- Germline Mutations in Predisposition Genes in Pediatric Cancer (2015) — 1,123 citations
- Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration. (2015) — 870 citations
- Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia (2014) — 1,229 citations
- THE GENOMIC LANDSCAPE OF HYPODIPLOID ACUTE LYMPHOBLASTIC LEUKEMIA (2013) — 682 citations
- Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia (2012) — 712 citations
- The genetic basis of early T-cell precursor acute lymphoblastic leukaemia (2012) — 1,571 citations
- The Tumor Lysis Syndrome (2011) — 1,021 citations
- Biology, risk stratification, and therapy of pediatric acute leukemias: an update. (2011) — 848 citations
- NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia. (2010) — 632 citations
- Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia (2009) — 1,317 citations
- EARLY T-CELL PRECURSOR LEUKEMIA: A SUBTYPE OF VERY HIGH-RISK ACUTE LYMPHOBLASTIC LEUKEMIA IDENTIFIED IN TWO INDEPENDENT COHORTS (2009) — 901 citations
- Treating childhood acute lymphoblastic leukemia without cranial irradiation. (2009) — 1,165 citations
- Rearrangement of CRLF2 in B-progenitor– and Down syndrome–associated acute lymphoblastic leukemia (2009) — 628 citations
- Acute lymphoblastic leukaemia. (2008) — 798 citations
- Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. (2008) — 697 citations
- BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros (2008) — 1,112 citations
- Treatment of acute lymphoblastic leukemia. (2006) — 996 citations